POLYPEPTIDE LABORATORIES A/S: Financial statements 2020
CVR: 19056201
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
POLYPEPTIDE LABORATORIES A/S (CVR 19056201) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 1,274,000 compared with DKK -824,000 the year before. Equity in the 2020 report amounted to DKK 66,450,000. The solvency ratio was 99.9%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 1,274,000
- Equity
- DKK 66,450,000
- Total Assets
- DKK 66,494,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 0 | 1.3 mio. | 66.5 mio. | - |
| 2019 | - | 24 t. | -824 t. | 65.2 mio. | - |
| 2018 | - | 0 | -1.5 mio. | 66 mio. | - |
| 2017 | - | 721 t. | -757 t. | 67.5 mio. | 0 |
| 2016 | - | 15.2 mio. | -3.3 mio. | 68.2 mio. | 12000 |
Official annual report
How creditworthy is POLYPEPTIDE LABORATORIES A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
POLYPEPTIDE LABORATORIES A/S has published its annual report for 2019. Gross profit came to DKK 24,000, and the net result was DKK -824,000.
About POLYPEPTIDE LABORATORIES A/S
POLYPEPTIDE LABORATORIES A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named A/S PSE NR. 4948. The management consists of Raoul Bernhardt. The board consists of Juan José Gonzalez Casanova (chair), Christina Ellen Del Vecchio and Raoul Bernhardt. The company is owned by PolyPeptide Laboratories Holding (PPL) AB. The company has 0 employees (2017). In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000.